Integrated Multi‐Omics Analysis of Human Cerebrospinal Fluid in Traumatic Spinal Cord Injury: An Exploratory Pilot Study
CNS Neuroscience & Therapeutics · 2026-11 · 32 (11)
DOI: 10.1002/cns.71242 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 02.11.2026. Verfasst von Wenkang Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
Acute traumatic spinal cord injury (TSCI) is a devastating neurological disorder with limited therapeutic options. We aimed to characterize the human cerebrospinal fluid (CSF) microenvironment to identify novel multi‐omics signatures and potential mechanistic hypotheses.
Methods
CSF from 13 acute cervical TSCI patients and 13 controls was prospectively collected. A discovery cohort ( n = 10) underwent untargeted proteomics and metabolomics. Following differential and functional enrichment analyses, sequential multi‐omics integration was applied to extract cross‐omics features. Prioritized candidates were subsequently validated via ELISA and targeted metabolomics in an independent validation cohort ( n = 16).
Results
We identified 216 differentially expressed proteins and 26 metabolites, highlighting extensive extracellular matrix remodeling alongside profound purine and amino acid metabolism dysregulation. Integrated analyses converged on downregulated mitochondrial aspartate aminotransferase (GOT2) as a candidate marker. Targeted correlation analysis revealed that GOT2 selectively associated with specific co‐mapped metabolites that were concurrently downregulated, notably methionine and 4‐acetamidobutanoic acid. The GOT2‐associated metabolic signature was experimentally validated in the independent cohort.
Conclusions
This exploratory multi‐omics study unveils the acute human TSCI molecular landscape, nominating a novel GOT2‐associated metabolic signature that warrants further mechanistic investigation regarding its pathogenic implications and potential therapeutic relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Southeast University, Nanjing, China.
- Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Neurosurgery, Zhongda Hospital, Southeast University, Nanjing, China.
- Department of Neurosurgery, Taikang Xianlin Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- College of Future Technology, The Hong Kong University of Science and Technology (Guangzhou), Guangzhou, China.
ORCID-Profile: Wenkang Jiang, Zetian Zhou, Ning Li
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Jiang, W., Wang, Y., Miao, W., Liu, H., Qiao, Q., Jiang, T., Shen, C., Zhou, Z., Cheng, H., & Li, N. (2026). Integrated Multi‐Omics Analysis of Human Cerebrospinal Fluid in Traumatic Spinal Cord Injury: An Exploratory Pilot Study. CNS Neuroscience & Therapeutics, 32(11). https://doi.org/10.1002/cns.71242
Vancouver
Jiang W, Wang Y, Miao W, Liu H, Qiao Q, Jiang T, et al. Integrated Multi‐Omics Analysis of Human Cerebrospinal Fluid in Traumatic Spinal Cord Injury: An Exploratory Pilot Study. CNS Neuroscience & Therapeutics. 2026;32(11). doi:10.1002/cns.71242
BibTeX
@article{Jiang2026,
author = {Jiang, Wenkang and Wang, Yao and Miao, Wei and Liu, Huandong and Qiao, Qiujiang and Jiang, Ting and Shen, Chenyan and Zhou, Zetian and Cheng, Huilin and Li, Ning},
title = {Integrated Multi‐Omics Analysis of Human Cerebrospinal Fluid in Traumatic Spinal Cord Injury: An Exploratory Pilot Study},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {11},
doi = {10.1002/cns.71242}
}
EUVIMED